Bio-Rad BioPlex 2200 HIV Ag-Ab assay gets FDA nod, differentiates between HIV-1 and HIV-2
by Staff from Outbreak News Today on (#F8K5)
The U.S. Food and Drug Administration today approved the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, the first FDA-approved diagnostic that differentiates between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens. Two major types of HIV have been identified: HIV-1 and HIV-2. HIV-1 is responsible for most HIV infections throughout ["]
